Pfizer claims positive COPD trial
Pfizer has reported positive data from a clinical trial of its Spiriva HandiHaler product.The drugs... Read more>Watson claims positive bladder gel
Watson has reported positive data from a clinical trial of its investigational oxybutynin gel... Read more>Hays is a global leader in specialist recruitment, placing professional candidates in permanent, temporary and interim positions.
With over 8,800 staff in 390 offices across 27 countries, last year we placed over 40,000 people in permanent jobs, and each week we place almost the same number in temporary assignments.
Hays is the largest publicly listed recruitment group in the UK, and is a FTSE 250 support services listed company. The table below illustrates the key financial results.
| Year ended 30 June | 2008 | 2007 | Growth |
| Turnover | £2,540.2 | £2110.2m | +20% |
| Net fees | £786.8 | £633.6m | +24% |
| Operating Profit (In £'s million) | £253.8 | £216.1m | +17% |
| Group Profit before Tax (In £'s million) | £249.1 | £211.7m | +18% |
| Dividend per share (pence) | 5.80p | 5.00p | +16% |
To find our more about Hays plc Investor Relations click here
Hays Pharma is part of the Hays Plc group of companies. To visit Hays international job portal, please click here